For the readers interested in the stock health of Clovis Oncology, Inc. (CLVS). It is currently valued at $9.37. When the transactions were called off in the previous session, Stock hit the highs of $9.89, after setting-off with the price of $9.67. Company’s stock value dipped to $9.24 during the trading on the day. When the trading was stopped its value was $9.71.
Clovis Oncology, Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $32.05 on 02/28/19, with the lowest value was $2.93 for the same time period, recorded on 10/28/19.
Clovis Oncology, Inc. (CLVS) full year performance was -61.31%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Clovis Oncology, Inc. shares are logging -70.76% during the 52-week period from high price, and 219.79% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.93 and $32.05.
The company’s shares, operating in the sector of healthcare managed to top a trading volume set approximately around 2.57 million for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Clovis Oncology, Inc. (CLVS) recorded performance in the market was -6.86%, having the revenues showcasing 77.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 578.04M, as it employees total of 468 workers.
Analysts verdict on Clovis Oncology, Inc. (CLVS)
During the last month, 2 analysts gave the Clovis Oncology, Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 6 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 7.74, with a change in the price was noted +4.82. In a similar fashion, Clovis Oncology, Inc. posted a movement of +105.23% for the period of last 100 days, recording 8,846,482 in trading volumes.
Clovis Oncology, Inc. (CLVS): Technical Analysis
Raw Stochastic average of Clovis Oncology, Inc. in the period of last 50 days is set at 22.00%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 51.97%. In the last 20 days, the company’s Stochastic %K was 60.05% and its Stochastic %D was recorded 59.21%.
Let’s take a glance in the erstwhile performances of Clovis Oncology, Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -6.86%. Additionally, trading for the stock in the period of the last six months notably improved by 81.84%, alongside a downfall of -61.31% for the period of the last 12 months. The shares increased approximately by 38.34% in the 7-day charts and went down by -3.86% in the period of the last 30 days. Common stock shares were driven by 77.68% during last recorded quarter.